Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine.
Saved in:
| Title: | Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine. |
|---|---|
| Authors: | Plaze, Marion1,2 (AUTHOR), Attali, David1,2,3 (AUTHOR), Prot, Matthieu1,4 (AUTHOR), Petit, Anne-Cécile1,5 (AUTHOR), Blatzer, Michael5 (AUTHOR), Vinckier, Fabien1,2 (AUTHOR), Levillayer, Laurine6 (AUTHOR), Chiaravalli, Jeanne7 (AUTHOR), Perin-Dureau, Florent8 (AUTHOR), Cachia, Arnaud9,10 (AUTHOR), Friedlander, Gérard2 (AUTHOR), Chrétien, Fabrice1,2,5,11 (AUTHOR), Simon-Loriere, Etienne1,4 (AUTHOR), Gaillard, Raphaël1,2,5 (AUTHOR) r.gaillard@ghu-paris.fr |
| Source: | International Journal of Antimicrobial Agents. Mar2021, Vol. 57 Issue 3, pN.PAG-N.PAG. 1p. |
| Database: | Environment Complete |
| ISSN: | 09248579 |
|---|---|
| DOI: | 10.1016/j.ijantimicag.2020.106274 |
